Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition

Frontiers in Behavioral Neuroscience

Volumn 7, Issue DEC, 2013, Pages

  Yamashita, Naoya ^a   Takahashi, Aoi ^a   Takao, Keizo ^b,c,d   Yamamoto, Toshifumi ^e   Kolattukudy, Pappachan ^f   Miyakawa, Tsuyoshi ^b,c,d,g   Goshima, Yoshio ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^g FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Comprehensive behavioral test; CRMP1; Hyperactivity; Knockout mouse; Mesocortical dopaminergic transmission; Prepulse inhibition; Schizophrenia

Indexed keywords

CHLORPROMAZINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; DOPAMINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTEXT DEPENDENT MEMORY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; EMOTIONAL DISORDER; ENDOPHENOTYPE; HYPERACTIVITY; LEARNING DISORDER; LONG TERM MEMORY; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; SCHIZOPHRENIA;

EID: 84891636743     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00216     Document Type: Article

References (61)

1. Amorapanth, P., Ledoux, J. E., and Nader, K. (2000). Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat. Neurosci. 3, 74-79.doi: 10.1038/71145
2. Anagnostaras, S. G., Gale, G. D., and Fanselow, M. S. (2001). Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11, 8-17.doi: 10.1002/1098-1063(2001)11:1<8::AID-HIP01015>3.3.C0;2-Z
3. Bader, V., Tomppo, L., Trossbach, S. V., Bradshaw, N. J., Prikulis, I., Leliveld, S. R., et al. (2012). Proteomic, genomic and translational approaches identifyCRMP1 for a role in schizophrenia and its underlying traits. Hum. Mol. Genet. 21, 4406-4418.doi: 10.1093/hmg/dds273
4. Beasley, C. L., Pennington, K., Behan, A., Wait, R., Dunn, M. J., and Cotter, D. (2006). Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414-3425.doi: 10.1002/pmic.200500069
5. Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., et al. (1999). Phosphorylation ofDARPP-32 byCdk5 modulates dopamine signalling in neurons. Nature 402, 669-671. doi: 10.1038/45251
6. Braff, D. L., and Geyer, M. A. (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47, 181-188.doi: 10.1001/archpsyc.1990.01810140081011
7. Bray, N. J., Leweke, F. M., Kapur, S., and Meyer-Lindenberg, A. (2010). The neurobiology of schizophrenia: new leads and avenues for treatment. Curr. Opin. Neurobiol. 20, 810-815.doi: 10.1016/j.conb.2010.09.008
8. Breier, A., Su, T. P., Saunders, R., Carson, R. E., Kolachana, B. S., De Bartolomeis, A., et al. (1997). Schizophrenia is associated with elevated amphetamine- induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U.S.A. 94, 2569-2574.doi: 10.1073/pnas.94.6.2569
9. Byk, T., Dobransky, T., Cifuentes-Diaz, C., and Sobel, A. (1996). Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J. Neurosci. 16, 688-701.
10. Charrier, E., Mosinger, B., Meissirel, C., Aguera, M., Rogemond, V., Reibel, S., et al. (2006). Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1(-/-) mice. Genes Cells 11, 1337-1352.doi: 10.1111/j.1365-2443.2006.01024.x
11. Cole, A. R., Causeret, F., Yadirgi, G., Hastie, C. J., McLauchlan, H., McManus, E.J., et al. (2006). Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J. Biol. Chem. 281, 16591-16598.doi: 10.1074/jbc. M513344200
12. Edgar, P. F., Douglas, J. E., Cooper, G. J., Dean, B., Kydd, R., and Faull, R. L. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry 5, 85-90.doi: 10.1038/sj.mp. 4000580
13. Engmann, O., Hortobagyi, T., Pidsley, R., Troakes, C., Bernstein, H. G., Kreutz, M. R., et al. (2011). Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 134, 2408-2421.doi: 10.1093/brain/awr155
14. Fatemi, S. H. (2005). Reelin glycoprotein: structure, biology and roles in health and disease. Mol. Psychiatry 10, 251-257.doi: 10.1038/sj.mp.4001613
15. Featherstone, R. E., Kapur, S., and Fletcher, P. J. (2007). The amphetamine-induced sensitized state as a model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1556-1571.doi: 10.1016/j.pnpbp.2007.08.025
16. Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J., and Radulovic, J. (2002). Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 22, 3700-3707.
17. Franklin, K., and Paxinos, G. (2007). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
18. Fukada, M., Watakabe, I., Yuasa-Kawada, J., Kawachi, H., Kuroiwa, A., Matsuda, Y., et al. (2000). Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J. Biol. Chem. 275, 37957-37965.doi: 10.1074/jbc.M003277200
19. Fukata, Y., Itoh, T. J., Kimura, T., Menager, C., Nishimura, T., Shiromizu, T., et al. (2002). CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591.doi: 10.1038/ncb825
20. Gainetdinov, R. R., Mohn, A. R., and Caron, M. G. (2001). Genetic animal models: focus on schizophrenia. Trends Neurosci. 24, 527-533.doi: 10.1016/S0166- 2236(00)01886-5
21. Garey, L. (2010). When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits. J. Anat. 217, 324-333.doi: 10.1111/j.1469-7580.2010.01231.x
22. Garey, L. J., Von Bussmann, K. A., and Hirsch, S. R. (2006). Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics. Exp. Brain Res. 173, 234-242.doi: 10.1007/s00221-006- 0396-8
23. Glantz, L. A., and Lewis, D. A. (2000). Decreased dendritic spine density on pre- frontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65-73.doi: 10.1001/archpsyc.57.1.65
24. Goshima, Y., Nakamura, F., Strittmatter, P., and Strittmatter, S. M. (1995). Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376, 509-514.doi: 10.1038/376509a0
25. Guan, J. S., Su, S. C., Gao, J., Joseph, N., Xie, Z., Zhou, Y., et al. (2011). Cdk5 is required for memory function and hippocampal plasticity via the cAMP signaling pathway. PLoS ONE 6:e25735.doi: 10.1371/journal.pone.0025735
26. Guidotti, A., Auta, J., Davis, J. M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57, 1061-1069.doi: 10.1001/archpsyc.57.11.1061
27. Hamajima, N., Matsuda, K., Sakata, S., Tamaki, N., Sasaki, M., and Nonaka, M. (1996). A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180, 157-163.doi: 10.1016/S0378-1119(96)00445-3
28. Hong, L. E., Wonodi, I., Avila, M. T., Buchanan, R. W., McMahon, R. P., Mitchell, D., et al. (2005). Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 136B, 8-11.doi: 10.1002/ajmg.b.30181
29. Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M. G., et al. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 95, 15718-15723.doi: 10.1073/pnas.95.26.15718
30. Inatome, R., Tsujimura, T., Hitomi, T., Mitsui, N., Hermann, P., Kuroda, S., et al. (2000). Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J. Biol. Chem. 275, 27291-27302.doi: 10.1074/jbc.M910126199
31. Jitsuki, S., Takemoto, K., Kawasaki, T., Tada, H., Takahashi, A., Becamel, C., et al. (2011). Serotonin mediates cross-modal reorganization of cortical circuits. Neuron 69, 780-792.doi: 10.1016/j.neuron.2011.01.016
32. Johnston-Wilson, N. L., Sims, C. D., Hofmann, J. P., Anderson, L., Shore, A. D., Torrey, E. F., et al. (2000). Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 5, 142-149.doi: 10.1038/sj.mp.4000696
33. Kolluri, N., Sun, Z., Sampson, A. R., and Lewis, D. A. (2005). Lamina- specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 162, 1200-1202.doi: 10.1176/appi.ajp.162.6.1200
34. Komada, M., Takao, K., and Miyakawa T. (2008). Elevatedplus maze for mice. J. Vis.Exp. 22:e1088.doi: 10.3791/1088
35. Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., and Innis, R. (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46, 56-72.doi: 10.1016/S0006-3223(99)00067-0
36. Lieberman, J. A., Kane, J. M., and Alvir, J. (1987). Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91, 415-433.doi: 10.1007/BF00216006
37. Minturn, J. E., Fryer, H. J., Geschwind, D. H., and Hockfield, S. (1995). TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J. Neurosci. 15, 6757-6766.
38. Morabito, M. A., Sheng, M., and Tsai, L. H. (2004). Cyclin-dependent kinase phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 24, 865-876.doi: 10.1523/JNEUROSCI.4582- 03.2004
39. Niisato, E., Nagai, J., Yamashita, N., Abe, T., Kiyonari, H., Goshima, Y., et al. (2012a). CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus. Dev. Neurobiol. 72, 1447-1457.doi: 10.1002/dneu.22007
40. Niisato, E., Nagai, J., Yamashita, N., Nakamura, F., Goshima, Y., and Ohshima, T. (2012b). Phosphorylation of CRMP2 is involved in proper bifurcation of the apical dendrite of hippocampal CA1 pyramidal neurons. Dev. Neurobiol. 73, 142-151.doi: 10.1002/dneu.22048
41. Paterlini, M., Zakharenko, S. S., Lai, W. S., Qin, J., Zhang, H., Mukai, J., et al. (2005). Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8, 1586-1594.doi: 10.1038/nn1562
42. Paule, M. G., Rowland, A. S., Ferguson, S. A., Chelonis, J. J., Tannock, R., Swanson, J. M., et al. (2000). Attention deficit/hyperactivity disorder: characteristics, interventions and models. Neurotoxicol. Teratol. 22, 631-651.doi: 10.1016/S0892-0362(00)00095-7
43. Paylor, R., and Crawley, J. N. (1997). Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132, 169-180.doi: 10.1007/s002130050333
44. Phillips, R. G., and Ledoux, J. E. (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274-285.doi: 10.1037/0735-7044.106.2.274
45. Pillai-Nair, N., Panicker, A. K., Rodriguiz, R. M., Gilmore, K. L., Demyanenko, G. P., Huang, J. Z., et al. (2005). Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J. Neurosci. 25, 4659-4671.doi: 10.1523/JNEUR0SCI.0565-05.2005
46. Quach, T. T., Massicotte, G., Belin, M. F., Honnorat, J., Glasper, E. R., Devries, A. C., et al. (2008). CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB J. 22, 401-409.doi: 10.1096/fj.07-9012com
47. Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M., and Coyle, J. T. (2006). Neurobiology of schizophrenia. Neuron 52, 139-153.doi: 10.1016/j.neuron.2006.09.015
48. Sakae, N., Yamasaki, N., Kitaichi, K., Fukuda, T., Yamada, M., Yoshikawa, H., et al. (2008). Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum. Mol. Genet. 17, 3191-3203.doi: 10.1093/hmg/ddn215
49. Su, K. Y., Chien, W. L., Fu, W. M., Yu, I. S., Huang, H. P., Huang, P. H., et al. (2007). Mice deficient in collapsin response mediator protein-1 exhibit impaired longterm potentiation and impaired spatial learning and memory. J. Neurosci. 27, 2513-2524.doi: 10.1523/JNEUR0SCI.4497-06.2007
50. Takao, K., and Miyakawa, T. (2006). Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice. Ann. N.Y. Acad. Sci. 1086, 144-159.doi: 10.1196/annals.1377.008
51. Tueting, P., Costa, E., Dwivedi, Y., Guidotti, A., Impagnatiello, F., Manev, R., et al. (1999). The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 10, 1329-1334.doi: 10.1097/00001756-19990426000032
52. Uchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., et al. (2005). Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance andAlzheimer's disease. Genes Cells 10,165-179.doi: 10.1111/j.1365-2443.2005.00827.x
53. Wang, L. H., and Strittmatter, S. M. (1996). A family of rat CRMP genes is differentially expressed in the nervous system. J. Neurosci. 16, 6197-6207.
54. Yamasaki, N., Maekawa, M., Kobayashi, K., Kajii, Y., Maeda, J., Soma, M., et al. (2008). Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain 1, 6.doi: 10.1186/1756-6606-1-6
55. Yamashita, N., and Goshima, Y. (2012). Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status. Mol. Neurobiol. 45, 234-246.doi: 10.1007/s12035-012-8242-4
56. Yamashita, N., Morita, A., Uchida, Y., Nakamura, F., Usui, H., Ohshima, T., et al. (2007). Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1. J. Neurosci. 27, 12546-12554.doi: 10.1523/JNEUR0SCI.3463- 07.2007
57. Yamashita, N., Mosinger, B., Roy, A., Miyazaki, M., Ugajin, K., Nakamura, F., et al. (2011). CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells. J. Neurosci. 31, 1773-1779.doi: 10.1523/JNEUR0SCI.5337-10.2011
58. Yamashita, N., Ohshima, T., Nakamura, F., Kolattukudy, P., Honnorat, J., Mikoshiba, K., et al. (2012). Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. J. Neurosci. 32, 1360-1365.doi: 10.1523/JNEUR0SCI.5563-11.2012
59. Yamashita, N., Uchida, Y., Ohshima, T., Hirai, S., Nakamura, F., Taniguchi, M., et al. (2006). Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration. J. Neurosci. 26, 13357-13362.doi: 10.1523/JNEUROSCI.4276-06.2006
60. Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., and Kaibuchi, K. (2005). GSK-3beta regulates phosphorylation of CRMP-and neuronal polarity. Cell 120, 137-149.doi: 10.1016/j.cell.2004. 11.012
61. Yuasa-Kawada, J., Suzuki, R., Kano, F., Ohkawara, T., Murata, M., and Noda, M. (2003). Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur. J. Neurosci. 17, 2329-2343.doi: 10.1046/j.1460-9568.2003.02664.x